Press Releases Items Per Page 102550 Year None202220212020201920182017201620152014 08-09-2022 Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update 08-02-2022 Daré Bioscience to Host Second Quarter 2022 Financial Results and Company Update Conference Call and Webcast on August 9, 2022 07-07-2022 Daré Bioscience to Participate in Maxim Group Women’s Health Panel 06-30-2022 Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis 06-24-2022 Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022 06-06-2022 Daré Bioscience to Participate in the 2022 BIO International Convention 05-16-2022 Daré Bioscience to Participate in H.C. Wainwright Global Investment Conference 05-12-2022 Daré Bioscience Reports First Quarter 2022 Financial Results and Provides a Company Update 05-11-2022 Daré Bioscience Announces NIH Grant Award 05-05-2022 Daré Bioscience to Host First Quarter 2022 Financial Results and Company Update Conference Call and Webcast on May 12, 2022 Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 19
08-09-2022 Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update
08-02-2022 Daré Bioscience to Host Second Quarter 2022 Financial Results and Company Update Conference Call and Webcast on August 9, 2022
06-30-2022 Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis
06-24-2022 Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022
05-12-2022 Daré Bioscience Reports First Quarter 2022 Financial Results and Provides a Company Update
05-05-2022 Daré Bioscience to Host First Quarter 2022 Financial Results and Company Update Conference Call and Webcast on May 12, 2022
